• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Voxel dispute slated for arbitration

Article

A dispute with its manufacturing partner has prompted holographicdisplay developer Voxel of Laguna Hills, CA, to begin lookingfor an alternative source for development and manufacturing ofits Voxcam systems. The dispute began in December, when

A dispute with its manufacturing partner has prompted holographicdisplay developer Voxel of Laguna Hills, CA, to begin lookingfor an alternative source for development and manufacturing ofits Voxcam systems. The dispute began in December, when Voxelannounced that it believed its current vendor—laser systemdeveloper General Scanning—was in breach of contract for allegedlyfailing to meet engineering specifications and delivery datesfor the Voxcam imager, a central element in Voxel's digital holographysystem (SCAN 1/22/97).

The dispute between Voxel and General Scanning, of Watertown,MA, is now headed for binding arbitration. Meanwhile, Voxel hasdecided to accelerate its alternative manufacturing program dueto several factors, such as tests by the company that Voxel believesconfirm the engineering shortcomings at the root of its disputewith General Scanning. Under its contract with General Scanning,Voxel had been prohibited from using another manufacturing partner,but that provision was waived when the dispute went to arbitration.

Voxel's alternative manufacturing program will include securingsubsystems from qualified vendors and will also include performingfinal assembly and testing in-house for a pilot production run.A system integrator for volume manufacturing will also be selected.

Recent Videos
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Teleradiology and Breast Imaging: Keys to Facilitating Personalized Service, Efficiency and Equity
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, MD, Part 3
Related Content
© 2025 MJH Life Sciences

All rights reserved.